- Home
- RLMD vs PET Comparison
RLMD vs PET Comparison
Compare RLMD & PET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- PET
- Stock Information
- Founded
- RLMD 2004
- PET 2015
- Country
- RLMD United States
- PET United States
- Employees
- RLMD N/A
- PET N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- PET EDP Services
- Sector
- RLMD Health Care
- PET Technology
- Exchange
- RLMD Nasdaq
- PET Nasdaq
- Market Cap
- RLMD 11.5M
- PET 10.7M
- IPO Year
- RLMD N/A
- PET N/A
- Fundamental
- Price
- RLMD $0.30
- PET $0.30
- Analyst Decision
- RLMD Hold
- PET Strong Buy
- Analyst Count
- RLMD 4
- PET 5
- Target Price
- RLMD $4.25
- PET $4.90
- AVG Volume (30 Days)
- RLMD 2.1M
- PET 900.1K
- Earning Date
- RLMD 03-18-2025
- PET 03-04-2025
- Dividend Yield
- RLMD N/A
- PET N/A
- EPS Growth
- RLMD N/A
- PET N/A
- EPS
- RLMD N/A
- PET N/A
- Revenue
- RLMD N/A
- PET $76,747,000.00
- Revenue This Year
- RLMD N/A
- PET N/A
- Revenue Next Year
- RLMD N/A
- PET $6.78
- P/E Ratio
- RLMD N/A
- PET N/A
- Revenue Growth
- RLMD N/A
- PET N/A
- 52 Week Low
- RLMD $0.28
- PET $0.14
- 52 Week High
- RLMD $7.22
- PET $2.47
- Technical
- Relative Strength Index (RSI)
- RLMD 30.81
- PET 48.46
- Support Level
- RLMD $0.28
- PET $0.29
- Resistance Level
- RLMD $0.36
- PET $0.38
- Average True Range (ATR)
- RLMD 0.04
- PET 0.05
- MACD
- RLMD 0.02
- PET -0.00
- Stochastic Oscillator
- RLMD 7.21
- PET 26.75
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About PET Wag! Group Co.
Wag Group Co develops and supports a proprietary marketplace technology platform available as a website and mobile app that enables independent Pet Caregivers to connect with pet parents. The platform allows pet parents to make pet service requests in the platform, which can then be fulfilled by Pet Caregivers. Wag supports dog walking, pet sitting, pet boarding, drop-in visits at the pet parent's home, advice from licensed pet experts, training services, pet insurance comparison tools, and pet wellness plans.